Gastric Cancer
Cancer
Gastric Cancer is treated with 1 medication in our database, including Keytruda. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Merck & Co.. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Gastric Cancer treatment below.
What help exists for Gastric Cancer
10
drugs indexed
9
with copay cards
8
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Gastric Cancer
10 totalKanjinti
trastuzumab-anns · Amgen
🎟💙TEVIMBRA
tislelizumab-jsgr · BeiGene
🎟💙HERZUMA
TRASTUZUMAB · Celltrion
🎟💙OGIVRI
trastuzumab-dkst · Biocon
🎟💙LONSURF
trifluridine and tipiracil · Taiho
🎟💙Trazimera
trastuzumab-qyyp · Pfizer
🎟💙Enhertu
Enhertu · Daiichi Sankyo and AstraZeneca
KEYTRUDA
pembrolizumab · Merck
🎟💙CYRAMZA
ramucirumab · Eli Lilly
🎟Ontruzant
trastuzumab · Samsung Bioepis
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Gastric Cancer drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 11 PA rules for Gastric Cancer drugs. View individual drug pages for complete PA detail.